Wishing All The Best For The Coming Christmas And New Year 2023 Festive Season

BREAKING NEWS
Cancer
Keeping you updated with all the latest developments, researches, drug trials and treatment protocols for cancer. For detailed information about cancer including cancer types, cancer treatments, cancer drugs, cancer care and also the best cancer hospitals and cancer doctors in Thailand, please visit our other website: www.thailandcancerhelp.com
Source: Immunotherapy  Jun 02, 2020  3 years ago
Immunotherapy: A research led by medical scientists from the Ohio State University Comprehensive Cancer Center has identified a protein called PCBP1 within certain immune cells that is required for optimal immune responses to cancer.   The study findings, reported in the journal Science Advances, also suggest that the protein might be useful for predicting which cancer patients&nb...
Source: ASCO20 Cancer Updates  May 30, 2020  3 years ago
ASCO20 Cancer Updates:  Medical researchers from the University College London (UCL) and University College London Hospitals NHS Foundation Trust (UCLH) in a recent large  international clinical trial have found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of patients with a specific subtype of advanced bowel cancer, when com...
Source: Cancer Diagnostics  May 29, 2020  3 years ago
Cancer Diagnostics: Biotech and medical researchers from the University of Birmingham are developing a new type of diagnostic test that uses complex sugars to detect prostate cancer earlier and with greater accuracy.   The new diagnostic test works by identifying sugars, known as glycans, in blood. These sugars are attached to protein molecules called PSA and are known to undergo ...
Source: Brain Cancer  May 27, 2020  3 years ago
Brain Cancer: Researchers from Virginia Commonwealth University Massey Cancer Center and Institute of Molecular Medicine (VIMM) have reported that lumefantrine, an FDA-approved drug used to treat malaria has demonstrated effectiveness to enhance existing treatment protocols to treat Glioblastoma multiforme (GBM), an aggressive form of cancer in the brain that is typically fatal.   The resea...
Source: Breast Cancer  May 26, 2020  3 years ago
Breast Cancer: Oncology researchers from University Of South Australia have made a significant breakthrough by discovering how an obscure protein causes breast cancer to develop and grow more quickly.   According to Associate Professor Dr Michael Samuel, a senior University Of South Australia researcher in the Centre for Cancer Biology (CCB), who spearheaded this research with co-lead scien...
Source: Cancer News  May 18, 2020  3 years ago
Cancer:  Medical and oncology researchers from the University of Eastern Finland have developed a new and promising pharmaceutical compound for the treatment of cancer that inhibits natural amino acids from entering cancer cells. Since amino acids are critical for the growth and division of cancer cells, the new LAT1 inhibitor makes it possible to inhibit the growth of cancer cells.   ...
Source: Cancer News  May 13, 2020  3 years ago
Cancer News: Medical and oncology researchers from University Of Southern California and the IFOM Cancer Institute in Milan have found that a fasting-mimicking diet could be more effective at treating some types of cancer including colorectal cancers when combined with vitamin C.   In research on animal models, the team found that the combination delayed tumor progression in multiple animal...
Source : Cancer News  May 05, 2020  3 years ago
Cancer: Oncology researchers at the University of Alberta are enhancing a breast cancer therapy by improving how the treatment is delivered.   Dr Hasan Uludag, a Professor in chemical and materials engineering, and his team have developed a chemical compound that allows them to effectively inject genetic material into cells. https://www.liebertpub.com/doi/10.1089/hum....
Source: Covid-19 News  Mar 27, 2020  3 years ago
According to a research letter published online March 25 in JAMA Oncology, patients with cancer in Wuhan had an increased risk for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infections. The journal warns that similar issues could also affect cancer patients elsewhere. (https://jamanetwork.com/journals/jamaoncology/fullarticle/2763673)   Dr Jing Yu, M.D., from the Zhon...
Source: Thailand Medical News  Feb 01, 2020  3 years ago
A new year-by-year age meta-analysis of colorectal cancer rates among U.S. adults and also adults globally finds a 46% increase in new diagnoses from ages 49 to 50, indicating that many latent cases of the disease are likely going undiagnosed until routine screenings begin at 50, according to a new study in JAMA Network Open. Lead study author Dr. Jordan Karlitz, associate clinical professo...
Source: Thailand Medical News  Jan 31, 2020  3 years ago
A new research study by oncology researchers at the University Of California Los Angeles Jonsson Comprehensive Cancer Center suggests that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusion of anti-tumor immune cells, or T cells, may produce a stronger immune response that could help fight advanced melanoma.   The researchers told T...
Source: Thailand Medical News  Jan 29, 2020  3 years ago
Medical and oncology researchers at the Johns Hopkins Kimmel Cancer Center in Baltimore, working with colleagues in the Netherlands, have developed a new ultrasensitive blood test that can predict recurrence of gastric cancer in patients after surgery. A description of their test, which is still experimental, was published online in the journal Nature Communications.   The medical inve...
Source: Thailand Medical News  Jan 19, 2020  3 years ago
Medical scientists at the University of Glasgow and Cancer Research UK Beatson Institute have tested close to 1000 existing medicines and discovered that a cheap drug commonly used to treat parasitic worm infection could be a game-changing treatment for prostate cancer. Prostate cancer is the most common cancer affecting men and the second most common cause of cancer death for men globally. &nbs...
Source: Thailand Medical News  Jan 18, 2020  3 years ago
Researchers from New Ohio State University have shown an association between breast cancer survivors' use of proton pump inhibitors (PPIs) and reports of problems with concentration and memory. On average, cognitive problems reported by PPI users were between 20 and 29 percent more severe than issues reported by non-PPI users. PPIs are sold under such brand names as Nexium, Prevacid ...
Source: Thailand Medical News  Dec 26, 2019  3 years ago
A new investigational cancer drug that targets tumors caused by mutations in the KRAS gene will be evaluated in phase 2 clinical trials, following promising safety and efficacy results in preliminary human studies and excellent results in animal studies. The drug, developed by Amgen and currently referred to as AMG 510, is the first therapy to reach clinical trials that inhibits a mutant KRAS prot...
Source: Thailand Medical News  Dec 21, 2019  3 years ago
Prostate Cancer According to a new University College of London-led computer modelling study, nearly one in six deaths from prostate cancer could be prevented if targeted screening was introduced for men at a higher genetic risk of the disease. Prostate cancer is the most common form of cancer in men with around 1.3 million new cases diagnosed globally each year and more than 400,000 men a yea...
Source: Thailand Medical News  Dec 19, 2019  3 years ago
Medical researchers at Children's Medical Center Research Institute at University Of Texas Southwestern (CRI) have uncovered why certain melanoma cells are more likely to spread through the body. The discovery opens up a potential new avenue of treatment and could be used to help reduce the proportion of patients who progress from stage 3 melanoma to more-deadly stage 4 cancer. Dr. Sean Mor...
Source: Thailand Medical News  Dec 15, 2019  3 years ago
Scientists from QIMR Berghofer Medical Research Institute, Brisbane have discovered a potential new cancer immunotherapy target that involves switching off a regulatory cell to stop tumors growing and spreading. The new study findings have been published today in Cancer Discovery, a journal of the American Association for Cancer Research. Associate Professor Dr Michele Teng, senior resear...
Source: Thailand Medical News  Dec 10, 2019  3 years ago
Oncologists who treat patients with the aggressive triple negative breast cancer have two new ways to predict which cancer patients may benefit most from the well-established post-surgery treatment known as AC chemotherapy, short for adjuvant doxorubicin and cyclophosphamide. Oncology researchers from the SWOG Cancer Research Network, a cancer clinical trials network funded by the National Canc...
Source: Thailand Medical News  Dec 05, 2019  3 years ago
Though prostate cancer is the most common cancer in men globally, we still have yet to know all of its causes. The largest ever study to use genetics as a measurement for physical activity to look at its effect on prostate cancer, reveals that being more active reduces the risk of prostate cancer. Over 140,000 men were included in the study, of which, 80,000 had prostate cancer. The study, publ...
Source: Thailand Medical News  Dec 04, 2019  3 years ago
A Phase 11 clinical trial involving a pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some men with advanced prostate cancer. The recently concluded phase II trial found that over 80 per cent of men with prostate cancer whose tumours had mutations in the BRCA genes responded well to treatment with the target...
Source: Thailand Medical News  Nov 30, 2019  3 years ago
Researchers from the University Of Buffalo have developed a new, portable breast imaging system that has the potential to better identify breast cancer in women with dense breast tissue. That is among the findings of a study published in the journal IEEE Transactions on Biomedical Engineering . The research study was led by University at Buffalo researchers in collaboration with Roswell...
Source: Thailand Medical News  Nov 30, 2019  3 years ago
Dr. David P. Labbé, a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), and his colleagues were recently able to discover what molecular events occur for prostate cancer to progress faster and to be deadlier when patients eat a high-fat diet in an extensive research study. In a study published in Nature Communications, they showed that saturated f...
Source: Thailand Medical News  Nov 28, 2019  3 years ago
Flavonoids which are phytochemicals found in fruits and vegetables, can help prevent colorectal cancer. Though studies conducted during the last 20 years have established this, scientists have struggled to determine how flavonoids are responsible for cancer prevention. Associate professor Jayarama Gunaje, left, and doctoral student Ranjini Sankaranarayanan of the Department of Pharmaceutical Sci...
Source: Thailand Medical News  Nov 28, 2019  3 years ago
Typically, it is a feeling that many who receive a cancer diagnosis can identify with: heartbreak and fear, followed by hopes that chemotherapy will save the day. Unfortunately, for many patients, chemo's painful side effects cause them to stop treatment prematurely. Fortunately, a research team headed by Professor Alexander Binshtok, head of the Pain Plasticity Research Group at the Hebrew U...
Source: Thailand Medical News  Nov 27, 2019  3 years ago
University of Western Ontario are conducting a new clinical study that looks to move doctors and patients closer to earlier and more precise detection of recurrent prostate cancer that would clarify treatment decisions and lead to more confident courses of action and better health outcomes. The multi-center trial registry testing the use of a new imaging tracer ie the prostate specific membrane a...
Source: Thailand Medical News  Nov 27, 2019  3 years ago
A new research by Peter MacCallum Cancer Centre has shed new light on why men are more likely than women to get cancer, uncovering a new role for the X chromosome in affecting cancer risk and mortality. While males are known to have a higher risk of developing, and dying from, cancer compared to women even when matched for other known cancer risk factors like age, race, smoking histor...
Source: Thailand Medical News  Nov 26, 2019  3 years ago
Globally, more than 1,180 individuals are diagnosed with pancreatic cancer each day. Within 12 months of diagnosis, 85% will die from it as its one of the most deadly cancers. Despite being lethal, a new research from the University of South Australia could help vastly improve the prognosis for pancreatic cancer patients. Utilizing  a new targeted radioimmunotherapy agent, UniSA Prof...
Source: Thailand Medical News  Nov 25, 2019  3 years ago
Lynparza or Olaparib, is a pharmacological inhibitor of the enzyme PARP (poly ADP Ribose polymerase or PARP) which is required for cancer cell DNA repair. In the presence of certain mutations like BRCA1 and BRCA2, Olaparib kills cancer cells. Olaparib is typically used to treat women suffering from ovarian and breast cancers, has shown promising results when administered to men in whom pro...
Source: Thailand Medical News  Nov 23, 2019  3 years ago
Overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma (HCC) significantly improves with a combination therapy using PD-L1 inhibitor atezolizumab (an immunotherapy drug)  and the VEGF inhibitor bevacizumab,  according to results from a phase 3 study reported at the ESMO Asia 2019 Congress. Dr Ann-Lii Cheng, Director of the National Taiwan...
Source: Thailand Medical News  Nov 22, 2019  3 years ago
Medical researchers from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and oncologists from the Centre Hospitalier Emile Mayrisch (CHEM) are in the process of developing a kit which could facilitate the detection of colorectal cancer at early stage and help clinicians choose the best treatment. Dr. Elisabeth Letellier, principal investig...
Source: Thailand Medical News  Nov 21, 2019  3 years ago
Thailand Cancer News Researchers from the University of Granada (UGR), the Institute of Nanoscience of Aragon (INA), the University of Zaragoza, and the Cancer Research UK Edinburgh Centre at the University of Edinburgh in a collaborative research and study are using “Trojan horses” to combat cancer from within the tumour cells themselves without damaging healthy tissues is the aim of...
Source: Thailand Medical News  Nov 21, 2019  3 years ago
Thailand Cancer News A joint research study by  Cold Spring Harbor Laboratory scientists along with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acute myeloid leukemia. The researchers are the first to demonstrate the anti-cancer effect of blocking the Salt-Inducible Kinase 3 (SIK3) pathway in...
Source: Thailand Medical News  Nov 21, 2019  3 years ago
Thailand Cancer News The University of Barcelona (UB) and Hospital Clínic de Barcelona entered into a collaboration with pharma giant, Boehringer Ingelheim Inc to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the treatment of lung cancer. This public-private collaboration enabled researchers  to identify molecular mechanisms underlying the lack of ...
Source: Thailand Medical News  Nov 21, 2019  3 years ago
Thailand Cancer A recent study by A QIMR Berghofer, a medical research institute in Queensland, Australia has identified how a newly approved blood cancer drug works and found the treatment is better than other drugs at targeting cancer stem cells while causing minimal damage to healthy cells. In mid-2018, the long-acting form of the drug Interferon alpha was approved for use in Australia...
Source: Thailand Medical News  Nov 19, 2019  3 years ago
A new study by researchers from the gastroenterology team at Henri-Mondor AP-HP Hospital and University Paris-Est Créteil, led by Professor Iradj Sobhani, together with teams from Inserm and the Institut Pasteur Molecular Microbial Pathogenesis Unit (U1202), led by Professor Philippe Sansonetti,holder of the Microbiology and Infectious Diseases Chair at the Collège de France,have dem...
Source: Thailand Medical News  Nov 13, 2019  3 years ago
Researchers at Purdue University have come up with a way to combine the anthrax toxin with a growth factor to kill bladder cancer cells and tumors. Anthrax may soon help more people win the fight against bladder cancer, which the Centers for Disease Control and Prevention says strikes about 72,000 Americans each year and kills about 16,000 and is one of the most expensive cancers to treat....
Source: Thailand Medical News  Nov 12, 2019  3 years ago
A new joint study by the University of Leeds and the University of Aberdeen have identified potential environmental risk factors and new targets for treating an aggressive form of breast cancer.The  new data was presented at the Society for Endocrinology annual conference in Brighton. The study suggests that exposure to common chemicals in our everyday environment may increase the risk of dev...
Source: Thailand Medical News  Nov 05, 2019  3 years ago
As a result of a growing incidence rate of colorectal cancer in the US and also globally, the American College of Physicians (ACP) has issued new revised guidelines that has been published in the Annals Of Internal Medicine.   The guidelines states that doctors should screen for colorectal cancer in average-risk adults who do not have symptoms between the ages of 50 and 75. The frequency of...
Source: Thailand Medical News  Nov 03, 2019  3 years ago
A new study led by Rice University bioscientist Dr Natashat Kirienko and postdoctoral researcher Svetlana Panina found that mitocans, anti-cancer drugs that target mitochondria, are particularly adept at killing leukemia cells, especially when combined with a glycolytic inhibitor, while leaving healthy blood cells in the same sample largely unaffected. The published findings, an open ...
Source: Thailand Medical News  Nov 01, 2019  3 years ago
Two new separate studies conducted by researchers at Massachusetts General Hospital and the other by a team from Univeristy Of Texas MD Anderson Cancer Center in Houston support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. The first study by Massa...
Source: Thailand Medical News  Oct 30, 2019  3 years ago
A recent study by scientists from Nara Institute of Science and Technology (NAIST) in Japan reports how an experimental drug agent stops cancer cells from growing. 12 years ago, Indonesian scientists initially reported pentagamavumon-1 (PGV-1), an analogue of a molecule found in turmeric and that has been since discovered to have anti-cancer effects. In the new study, tests on cancer cells and ani...
Source: Thailand Medical News  Oct 30, 2019  3 years ago
Tohoku University researchers in Japan are studying using soundwaves to target sites for drug delivery to treat metastatic breast cancer. Drugs can be safely delivered to cancerous lymph nodes via the lymphatic system and then released inside the nodes using sound waves. The researchers have so far tested the treatment on animal models with metastatic breast cancer and have published their finding...
Source: Thailand Medical News  Oct 29, 2019  3 years ago
Medical researchers from the Bellvitge Biomedical Research Institute (IDIBELL) in Spain have discovered the critical involvement of a cell membrane protein in the development and progression of liver cancer. Clathrin, the protein is known for its key role in the process of internalization of molecules from the extracellular space into the cell, called endocytosis. In this process, the cell memb...
Source: Thailand Medical News  Oct 29, 2019  3 years ago
Medical researchers at Stevens Institute of Technology, New Jersey, US have developed a technique using shortwave rays used in cellphones and airport security scanners, that detects skin lesions and determines whether they are cancerous or benign, a technology that could ultimately be incorporated into a handheld device that could rapidly diagnose skin cancer without a scalpel in sight.   C...
Source: Thailand Medical News  Oct 24, 2019  3 years ago
A latest medical study conducted by Mayo Clinic indicates that a high consumption of dairy products, like milk and cheese increases the risk of developing prostate cancer. The findings of the study has also been published in the Journal of the American Osteopathic Association. At the same time the study showed that plant-based diets played a critical role in decreasing the risk of developing ...
Source: Thailand Medical News  Oct 23, 2019  3 years ago
A new study by the US National Cancer Institute (NCI) shows patients with a rare and life-threatening form of gastrointestinal cancer called Biliary Tract Cancer might live longer if they are aspirin users, with the greatest effect seen in those who had not taken the drug before their cancer diagnosis, the results of a database analysis indicate. The new study however only shows corre...
Source: Thailand Medical News  Oct 21, 2019  3 years ago
Researchers from Sloan Kettering Institute are exploring new ways to deal with cancer including using iron. Cells can die in several ways. One such method, discovered only within the past ten years, is ferroptosis literally, death by the mineral iron. This type of cell death requires iron and is linked to a cell’s use of oxygen for metabolism. Ferroptosis is a main cause of ische...
Source: Thailand Medical News  Oct 20, 2019  3 years ago
Typically the standard treatment protocol for the last 8 years for males with enlarged prostate is a type of drug called a 5-alpha reductase inhibitor (5-ARI). These US FDA approved drugs that also used globally, shrink the gland to improve urinary flow, and the approved forms used for treating enlarged prostates come in two varieties: Proscar (finasteride) and Avodart (dutasteride).However, these...
Source: Thailand Medical News  Oct 16, 2019  3 years ago
Medical researchers from Massey University in New Zealand are developing a new drug that could prevent cancer from becoming resistant to treatment. Treatment resistance is a serious obstacle to the successful treatment of cancer patients because it leads to cancer returning and becoming harder to treat. The drugs being developed blocks an enzyme called APOBEC3B in cancer cells that is re...
Source: Thailand Medical News  Oct 12, 2019  3 years ago
A new study by University of Strathclyde has led to a promising blood test that doctors may soon use to accurately detect brain cancer. The patented technology uses infrared light to produce a "bio-signature" of a blood sample and applies artificial intelligence to check for the signs of cancer.     According to the National Cancer Institute, around 0.6% of people will ...
Source: Thailand Medical News  Oct 11, 2019  3 years ago
Medical researchers from across the Netherlands have discovered that using organoids derived from patient tumors can be used to help determine how well a cancer patient will respond to chemotherapy. In their paper published in the journal Science Translational Medicine, the group describes growing organoids from tumor tissue and testing them with chemo drugs. Organoids are organs grown art...
Source: Thailand Medical News  Oct 08, 2019  3 years ago
Largest study ever that expanded over 3 decades and involved 36,000 participants indicates that an antioxidant found in mushrooms, L-ergothioneine lowers the risks of prostate cancer. Medical Researchers From Tohoku University in Sendai, Japan have discovered through a long term study that involved more than 36,000 Japanese men, that eating mushrooms effectively  lowered the risk of prostate ...
Source: Thailand Medical News  Oct 06, 2019  3 years ago
Since an initial study that was published in February 2017 in the Journal of the National Cancer Institute that showed rates of colorectal cancer have increased for every generation born since 1950, newer studies are emerging each year showing the worrisome trend and with headlines like: “If you’re under 30, your risk for colon cancer just doubled.” “Study finds colore...
Source: Thailand Medical News  Oct 05, 2019  3 years ago
When fungus get into the Gut and other digestive tract organs like the pancreas, it indirectly triggers cancer and other ailments.  With pancreatic cancer, colorectal cancer and also inflammatory bowel diseases on the rise, a team of medical researchers from New York University (NYU) School of Medicine decided to pursues studies focusing on the cause of pancreatic cancer an ddiscovered that a...

MOST READ

Sep 08, 2022  3 months ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 13, 2020  2 years ago
Source: Supplements For COVID-19
Feb 05, 2020  3 years ago
Source : Thailand Medical news

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  3 years ago
Source: Nitric Oxide and COVID-19
Jun 15, 2020  3 years ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  3 years ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  3 years ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  3 years ago
Source: Myocardial Injury
Jun 09, 2020  3 years ago
Source: COVID-19 News
May 21, 2020  3 years ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  3 years ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  3 years ago
Source : Thailand Medical News
Feb 11, 2020  3 years ago